Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1995
11/07/1995US5464936 Compositions for identification of papillomavirus replication inhibitors
11/07/1995US5464933 Synthetic peptide inhibitors of HIV transmission
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/07/1995US5464634 Red blood cell surrogate
11/07/1995US5464630 Liposomes that provide thymic dependent help to weak vaccine antigens
11/07/1995US5464621 Canine corona virus vaccine
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/02/1995WO1995029248A1 HERPES VIRUS TRANSFORMED TO EXPRESS gD $i(IN VITRO)
11/02/1995WO1995029240A1 Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029190A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995WO1995029180A1 Porphocyanine and cnc-expanded porphyrins
11/02/1995WO1995028960A1 Group a streptococcal polysaccharide immunogenic compositions and methods
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028915A1 Red blood cell surrogate
11/02/1995WO1995028838A1 Modified amino acids for drug delivery
11/02/1995EP0679403A1 Preventive and remedy for allergic disease
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679189A1 Cloning of enterokinase and method of use
11/02/1995EP0679187A1 Process for recovering native domains of viral membrane proteins, their use, in particular as vaccine against hiv.
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679182A1 Delivery of gene products via mesangial cells
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995EP0551401B1 Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188470A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells
11/02/1995CA2188467A1 Modified amino acids for drug delivery
11/02/1995CA2188397A1 Human sperm diagnostic
11/02/1995CA2177066A1 Red blood cell surrogate
11/01/1995CN1111058A Inhibitor of collagen-stimulated platelet aggregation
11/01/1995CN1110926A Method for producing refined hepatitis B highly specific transfer factor
10/1995
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462872 Human lymphoid cells expressing human immunodeficiency virus envelope protein GP160
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462853 Contacting samples with lectin to form specific binding complexes between the lectin and components of the sample, determining amount of the complexes, and correlating this amount to the amount of the components in the sample
10/31/1995US5462751 Biological and pharmaceutical agents having a nanomeric biodegradable core
10/31/1995US5462750 Metal, ceramic or polymeric particles coated with sugars or oligonucleotides which adsorb active materials, for drug delivery or medical diagnosis
10/31/1995US5462735 Pasteurella haemolytica subunit vaccine containing capsular polysaccharide and muramyl dipeptide
10/31/1995US5462734 Parenteal administering first vaccination containing bovin herpese virus glycoprotein capable of systemic immune response and a carrier, second vaccine with cholera toxin adjuvant capable of mucosal immune response applied to mucosa tissues
10/31/1995US5462733 Immune system modulation using psoralens activated with visible light
10/26/1995WO1995028642A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995WO1995028488A1 NON-SPLICING VARIANTS OF gp350/220
10/26/1995WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028227A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/26/1995WO1995028176A1 Method of treating hiv infection using antibodies against cytotoxic t-cells and thymic humoral factor
10/26/1995WO1995028175A1 Viral ribonucleocapsid as an immunological enhancer
10/26/1995WO1995014091A3 Compositions and methods for utilizing conditionally lethal genes
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy
10/26/1995CA2187779A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995CA2187768A1 Aqueous solvent encapsulation method, apparatus and microcapsules
10/25/1995EP0678744A2 Method for detecting urinary tumor associated antigens
10/25/1995EP0678577A2 Method for the production of recombinant human LH-RH receptor proteins
10/25/1995EP0678523A1 Recombinant anti-hiv antibody and preparation thereof
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678035A1 Vaccine preparations
10/25/1995EP0678034A1 Inducing cytotoxic t lymphocyte responses
10/25/1995EP0678033A1 Human aids vaccine from revertant cattle virus
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/24/1995US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP
10/24/1995US5460960 Isolating antibodies produced by a hapten similar to both the reactant and catalyst; modifying these antibodies by binding a converting hapten for the reactant/actual catalyst complex
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460831 Targeted transfection nanoparticles
10/24/1995US5460830 Biochemically active agents for chemical catalysis and cell receptor activation
10/24/1995US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus
10/24/1995US5460813 Method for treating Kawasaki syndrome by administration of an anti-TSST-1 agent which is not gamma globulin
10/24/1995US5460797 Method for fixing tissues and cells for analysis using oxazolidine compounds
10/24/1995US5460785 Direct labeling of antibodies and other protein with metal ions
10/24/1995CA1337403C Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones
10/24/1995CA1337402C Carrier for affinity chromatography immobilized antibodies and preparation thereof
10/24/1995CA1337395C Recombinant herpes simplex gb-gd vaccine
10/20/1995CA2147344A1 Receptor expression cells and use thereof
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027786A1 Pharmaceutical formulations for treating japanese cedar pollen allergy
10/19/1995WO1995027784A1 Cisplatin resistance gene and uses therefor
10/19/1995WO1995027780A1 Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
10/19/1995WO1995027736A1 Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027733A1 Hepatitis c virus core peptide for stimulation of cytotoxic t lymphocytes and diagnosis of hcv exposure
10/19/1995WO1995027508A1 Composition for use in raising an immune response
10/19/1995WO1995027507A1 Immunodeficiency recombinant poxvirus
10/19/1995WO1995027506A1 Catalase-based anti-helicobacter pylori immunising composition
10/19/1995WO1995027505A1 Cellular immune response-specific antigens and uses therefor
10/19/1995WO1995027504A1 Borrelia burgdorferi bacterin
10/19/1995WO1995027500A1 TREATMENT OF AUTOIMMUNE DISEASE USING ORAL TOLERIZATION AND/OR Th2-ENHANCING CYTOKINES
10/19/1995WO1995027499A1 Treatment of autoimmune disease using oral tolerization and/or type i interferon
1 ... 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 ... 1823